Weight Changes With Schizophrenic Psychosis and Psychotropic Drug Therapy

Psychosomatics

Volumn 11, Issue 6, 1970, Pages 551-561

  Holden, J M C ^a   Holden, U P ^b  

^a MISSOURI INSTITUTE OF MENTAL HEALTH   (United States)

^b Community Health Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORDIAZEPOXIDE; CHOLESTEROL; HEMOGLOBIN; PLACEBO;

ADULT; AGE; ARTICLE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEMATOCRIT; HUMAN; MALE; MENTAL DISEASE; OBESITY; PARANOID PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGE FACTORS; BODY WEIGHT; CHLORDIAZEPOXIDE; CHOLESTEROL; CHRONIC DISEASE; CLINICAL TRIALS; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; MENTAL DISORDERS; OBESITY; PARANOID DISORDERS; PLACEBOS; SCHIZOPHRENIA;

EID: 0014879380     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(70)71576-4     Document Type: Article

References (36)

1. The Biochemistry of Affective Disorders
2. Body weight and balance of water, sodium and potassium in depressed patients given electroconvulsive therapy
3. Weight change during and after hospital treatment
4. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: Side effects and clinical laboratory findings
5. Experience with large scale interhospital cooperative research in chemotherapy
6. Drug-produced obesity, experience with chiorpromazine, perphenazine and clopenthixol
7. Clinical biochemical and physiological studies in cases of recurrent schizophrenia
8. Rapid weight changes in mental patients
9. Beitrage zur Somatologie der periodischen Katatonie VII
10. Changes in weight in patients receiving a tranquilizing drug
11. Weight changes in relation to the characteristics of patients on chlorpromazine
12. Serial biochemical and endocrine investigations in recurrent mental illness
13. Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia
14. Laboratory changes with chlordlazepoxide and thioridazine alone and combined
15. Treatment of chronic psychotic patients, with combined medications
16. Psychopathological and psychosomatic rating scales
17. The Brief Psychiatric Rating Scale
18. New weight standards for men and women
19. Komplikationer vid langvarig chiorpromazin–behandling
20. Influence of chiorpromazine on certain biochemical variables of chronic male schizophrenics
21. The effect of chlorpromazine on water and electrolyte balance
22. The effects of caloric restriction on behavior and body weight in psychiatric subjects on chiorpromazine
23. Physiological and pharmacological aspects of the control of hunger and thirst
24. The regulation of food intake and obesity
25. Modification of hypothalamic neurosecretion by a neuroleptic
26. Leading Articles, The, Hypothalamus
27. Mechanism of unexpected adrenergic effect from hypothalamic injection of chiorpromazine
28. The application of automated techniques in assessing psychotropic-drug-induced side effects
29. Changes in laboratory values with butaperazine
30. Comparison of perphenazine and P-5227 in Chronic Schizophrenics: clinical and EEG effects
31. Serum cholesterol evaluation with trifluoperazine (Stelazine) therapy
32. Relationship between relative body weight and serum lipid levels